Industry Research Reports

Home > Reports > Chemical & Material > Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-08-01

Pages: 137 Pages

Report ld: 5508588

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Nicotinamide Mononucleotide (NMN) Market Trends: at a CAGR of 13.4% during the forecast period

Nicotinamide Mononucleotide (NMN) Market Size(US$)

CAGR 2026-2032

9.2%

Market Size,2032

USD 382

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 226 million

Market Forecast in 2032(Value)

US$ 382 million

CAGR

9.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 190 million in 2025 and is projected to reach US$ 382 million, growing at a CAGR of 9.2% from 2026 to 2032.

In 2025, global sales volume of Nicotinamide Mononucleotide (NMN) reached 397.8 metric tons, with an average price of $478 per kilogram.

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.

With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.

Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 82% of the total sales of nicotinamide mononucleotide in 2025.

MARKET SEGMENTATION

By Company

GeneHarbor (HK)
Herbalmax (US)
Genex Formulas (US)
Mirailab Bioscience (JP)
Maac10 Formulas (US)
EffePharm (CN)
Bontac (CN)
CELFULL (US)
Kingdomway (CN)
ABA Chemical (CN)
SyncoZymes (CN)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Content ≥98%
Content ＜98%

Segment by Application

Health Care Products
Cosmetics
Others

Segment by Category

Enzymatic Catalysis
Microbial Fermentation
Chemical Synthesis
Other

Segment by Division

Food Grade
Cosmetic Grade
Pharmaceutical Grade

biaoTi REPORT SCOPE

This report provides a comprehensive view of the global market for Nicotinamide Mononucleotide (NMN), covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide (NMN).

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Nicotinamide Mononucleotide (NMN) manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Nicotinamide Mononucleotide (NMN) sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Nicotinamide Mononucleotide (NMN) sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Nicotinamide Mononucleotide (NMN) Product Introduction

1.2 Global Nicotinamide Mononucleotide (NMN) Market Size Forecast

1.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value (2021–2032)

1.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume (2021–2032)

1.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Price (2021–2032)

1.3 Nicotinamide Mononucleotide (NMN) Market Trends & Drivers

1.3.1 Nicotinamide Mononucleotide (NMN) Industry Trends

1.3.2 Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunities

1.3.3 Nicotinamide Mononucleotide (NMN) Market Challenges

1.3.4 Nicotinamide Mononucleotide (NMN) Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (2025)

2.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2021–2026)

2.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume Ranking of Players (2025)

2.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Company (2021–2026)

2.5 Global Nicotinamide Mononucleotide (NMN) Average Price by Company (2021–2026)

2.6 Key Manufacturers Nicotinamide Mononucleotide (NMN) Manufacturing Base and Headquarters

2.7 Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Offerings

2.8 Key Manufacturers Start of Mass Production of Nicotinamide Mononucleotide (NMN)

2.9 Nicotinamide Mononucleotide (NMN) Market Competitive Analysis

2.9.1 Nicotinamide Mononucleotide (NMN) Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Nicotinamide Mononucleotide (NMN) Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Nicotinamide Mononucleotide (NMN) revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Nicotinamide Mononucleotide (NMN) Market Classification

3.1 Introduction by Type

3.1.1 Content ≥98%

3.1.2 Content ＜98%

3.1.3 Global Nicotinamide Mononucleotide (NMN) Sales Value by Type

3.1.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Type (2021–2032)

3.1.3.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Type (%), 2021–2032

3.1.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type

3.1.4.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (2021–2032)

3.1.4.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (%), 2021–2032

3.1.5 Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2021–2032)

3.2 Introduction by Production Process

3.2.1 Enzymatic Catalysis

3.2.2 Microbial Fermentation

3.2.3 Chemical Synthesis

3.2.4 Other

3.2.5 Global Nicotinamide Mononucleotide (NMN) Sales Value by Production Process

3.2.5.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Production Process (2021 vs 2025 vs 2032)

3.2.5.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Production Process (2021–2032)

3.2.5.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Production Process (%), 2021–2032

3.2.6 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Production Process

3.2.6.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Production Process (2021 vs 2025 vs 2032)

3.2.6.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Production Process (2021–2032)

3.2.6.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Production Process (%), 2021–2032

3.2.7 Global Nicotinamide Mononucleotide (NMN) Average Price by Production Process (2021–2032)

3.3 Introduction by Grade

3.3.1 Food Grade

3.3.2 Cosmetic Grade

3.3.3 Pharmaceutical Grade

3.3.4 Global Nicotinamide Mononucleotide (NMN) Sales Value by Grade

3.3.4.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Grade (2021 vs 2025 vs 2032)

3.3.4.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Grade (2021–2032)

3.3.4.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Grade (%), 2021–2032

3.3.5 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Grade

3.3.5.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Grade (2021 vs 2025 vs 2032)

3.3.5.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Grade (2021–2032)

3.3.5.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Grade (%), 2021–2032

3.3.6 Global Nicotinamide Mononucleotide (NMN) Average Price by Grade (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Health Care Products

4.1.2 Cosmetics

4.1.3 Others

4.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Application

4.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Application (2021–2032)

4.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Application (%), 2021–2032

4.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application

4.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (2021–2032)

4.3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (%), 2021–2032

4.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region

5.1.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2021–2026)

5.1.3 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2027–2032)

5.1.4 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2021–2032

5.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region

5.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2021–2026)

5.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2027–2032)

5.2.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (%), 2021–2032

5.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

5.4.2 North America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

5.5.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

5.6.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

5.7.2 South America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

5.8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value and Sales Volume

6.2.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

6.2.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

6.3.2 United States Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

6.4.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

6.5.2 China Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

6.5.3 China Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

6.6.2 Japan Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

6.7.2 South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

6.8.2 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032

6.9.2 India Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

6.9.3 India Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 GeneHarbor (HK)

7.1.1 GeneHarbor (HK) Company Information

7.1.2 GeneHarbor (HK) Introduction and Business Overview

7.1.3 GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Product Offerings

7.1.5 GeneHarbor (HK) Recent Developments

7.2 Herbalmax (US)

7.2.1 Herbalmax (US) Company Information

7.2.2 Herbalmax (US) Introduction and Business Overview

7.2.3 Herbalmax (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Herbalmax (US) Nicotinamide Mononucleotide (NMN) Product Offerings

7.2.5 Herbalmax (US) Recent Developments

7.3 Genex Formulas (US)

7.3.1 Genex Formulas (US) Company Information

7.3.2 Genex Formulas (US) Introduction and Business Overview

7.3.3 Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Product Offerings

7.3.5 Genex Formulas (US) Recent Developments

7.4 Mirailab Bioscience (JP)

7.4.1 Mirailab Bioscience (JP) Company Information

7.4.2 Mirailab Bioscience (JP) Introduction and Business Overview

7.4.3 Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Product Offerings

7.4.5 Mirailab Bioscience (JP) Recent Developments

7.5 Maac10 Formulas (US)

7.5.1 Maac10 Formulas (US) Company Information

7.5.2 Maac10 Formulas (US) Introduction and Business Overview

7.5.3 Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Product Offerings

7.5.5 Maac10 Formulas (US) Recent Developments

7.6 EffePharm (CN)

7.6.1 EffePharm (CN) Company Information

7.6.2 EffePharm (CN) Introduction and Business Overview

7.6.3 EffePharm (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 EffePharm (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

7.6.5 EffePharm (CN) Recent Developments

7.7 Bontac (CN)

7.7.1 Bontac (CN) Company Information

7.7.2 Bontac (CN) Introduction and Business Overview

7.7.3 Bontac (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Bontac (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

7.7.5 Bontac (CN) Recent Developments

7.8 CELFULL (US)

7.8.1 CELFULL (US) Company Information

7.8.2 CELFULL (US) Introduction and Business Overview

7.8.3 CELFULL (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 CELFULL (US) Nicotinamide Mononucleotide (NMN) Product Offerings

7.8.5 CELFULL (US) Recent Developments

7.9 Kingdomway (CN)

7.9.1 Kingdomway (CN) Company Information

7.9.2 Kingdomway (CN) Introduction and Business Overview

7.9.3 Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

7.9.5 Kingdomway (CN) Recent Developments

7.10 ABA Chemical (CN)

7.10.1 ABA Chemical (CN) Company Information

7.10.2 ABA Chemical (CN) Introduction and Business Overview

7.10.3 ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

7.10.5 ABA Chemical (CN) Recent Developments

7.11 SyncoZymes (CN)

7.11.1 SyncoZymes (CN) Company Information

7.11.2 SyncoZymes (CN) Introduction and Business Overview

7.11.3 SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)

7.11.4 SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

7.11.5 SyncoZymes (CN) Recent Developments

8 Industry Chain Analysis

8.1 Nicotinamide Mononucleotide (NMN) Industrial Chain

8.2 Nicotinamide Mononucleotide (NMN) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Nicotinamide Mononucleotide (NMN) Sales Model

8.5.2 Sales Channels

8.5.3 Nicotinamide Mononucleotide (NMN) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Nicotinamide Mononucleotide (NMN) Market Trends

Table 2. Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunities

Table 3. Nicotinamide Mononucleotide (NMN) Market Challenges

Table 4. Nicotinamide Mononucleotide (NMN) Market Restraints

Table 5. Global Nicotinamide Mononucleotide (NMN) Revenue by Company (US$ Million), 2021–2026

Table 6. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2021–2026)

Table 7. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Company (Tons), 2021–2026

Table 8. Global Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Nicotinamide Mononucleotide (NMN) Price by Company (US$/Kg), 2021–2026

Table 10. Key Manufacturers Nicotinamide Mononucleotide (NMN) Manufacturing Base and Headquarters

Table 11. Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Type

Table 12. Key Manufacturers Start of Mass Production of Nicotinamide Mononucleotide (NMN)

Table 13. Global Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Nicotinamide Mononucleotide (NMN) revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Nicotinamide Mononucleotide (NMN) Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Type (2021–2026)

Table 20. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Type (2027–2032)

Table 21. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)

Table 22. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (Tons), 2021–2026

Table 23. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (Tons), 2027–2032

Table 24. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Nicotinamide Mononucleotide (NMN) Price by Type (US$/Kg), 2021–2026

Table 27. Global Nicotinamide Mononucleotide (NMN) Price by Type (US$/Kg), 2027–2032

Table 28. Global Nicotinamide Mononucleotide (NMN) Sales Value by Production Process: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Nicotinamide Mononucleotide (NMN) Sales Value by Production Process (US$ Million), 2021–2026

Table 30. Global Nicotinamide Mononucleotide (NMN) Sales Value by Production Process (US$ Million), 2027–2032

Table 31. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Production Process (2021–2026)

Table 32. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Production Process (2027–2032)

Table 33. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Production Process: 2021 vs 2025 vs 2032 (Tons)

Table 34. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Production Process (Tons), 2021–2026

Table 35. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Production Process (Tons), 2027–2032

Table 36. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Production Process (2021–2026)

Table 37. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Production Process (2027–2032)

Table 38. Global Nicotinamide Mononucleotide (NMN) Price by Production Process (US$/Kg), 2021–2026

Table 39. Global Nicotinamide Mononucleotide (NMN) Price by Production Process (US$/Kg), 2027–2032

Table 40. Global Nicotinamide Mononucleotide (NMN) Sales Value by Grade: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Global Nicotinamide Mononucleotide (NMN) Sales Value by Grade (US$ Million), 2021–2026

Table 42. Global Nicotinamide Mononucleotide (NMN) Sales Value by Grade (US$ Million), 2027–2032

Table 43. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Grade (2021–2026)

Table 44. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Grade (2027–2032)

Table 45. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Grade: 2021 vs 2025 vs 2032 (Tons)

Table 46. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Grade (Tons), 2021–2026

Table 47. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Grade (Tons), 2027–2032

Table 48. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Grade (2021–2026)

Table 49. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Grade (2027–2032)

Table 50. Global Nicotinamide Mononucleotide (NMN) Price by Grade (US$/Kg), 2021–2026

Table 51. Global Nicotinamide Mononucleotide (NMN) Price by Grade (US$/Kg), 2027–2032

Table 52. Global Nicotinamide Mononucleotide (NMN) Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 53. Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (US$ Million), 2021–2026

Table 54. Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (US$ Million), 2027–2032

Table 55. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Application (2021–2026)

Table 56. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Application (2027–2032)

Table 57. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)

Table 58. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (Tons), 2021–2026

Table 59. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (Tons), 2027–2032

Table 60. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Application (2021–2026)

Table 61. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Application (2027–2032)

Table 62. Global Nicotinamide Mononucleotide (NMN) Price by Application (US$/Kg), 2021–2026

Table 63. Global Nicotinamide Mononucleotide (NMN) Price by Application (US$/Kg), 2027–2032

Table 64. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 65. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (US$ Million), 2021–2026

Table 66. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (US$ Million), 2027–2032

Table 67. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2021–2026

Table 68. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2027–2032

Table 69. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (Tons): 2021 vs 2025 vs 2032

Table 70. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (Tons), 2021–2026

Table 71. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (Tons), 2027–2032

Table 72. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (%), 2021–2026

Table 73. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (%), 2027–2032

Table 74. Global Nicotinamide Mononucleotide (NMN) Average Price by Region (US$/Kg), 2021–2026

Table 75. Global Nicotinamide Mononucleotide (NMN) Average Price by Region (US$/Kg), 2027–2032

Table 76. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 77. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value, (US$ Million), 2021–2026

Table 78. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value, (US$ Million), 2027–2032

Table 79. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume, (Tons), 2021–2026

Table 80. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume, (Tons), 2027–2032

Table 81. GeneHarbor (HK) Company Information

Table 82. GeneHarbor (HK) Introduction and Business Overview

Table 83. GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 84. GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 85. GeneHarbor (HK) Recent Developments

Table 86. Herbalmax (US) Company Information

Table 87. Herbalmax (US) Introduction and Business Overview

Table 88. Herbalmax (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 89. Herbalmax (US) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 90. Herbalmax (US) Recent Developments

Table 91. Genex Formulas (US) Company Information

Table 92. Genex Formulas (US) Introduction and Business Overview

Table 93. Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 94. Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 95. Genex Formulas (US) Recent Developments

Table 96. Mirailab Bioscience (JP) Company Information

Table 97. Mirailab Bioscience (JP) Introduction and Business Overview

Table 98. Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 99. Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 100. Mirailab Bioscience (JP) Recent Developments

Table 101. Maac10 Formulas (US) Company Information

Table 102. Maac10 Formulas (US) Introduction and Business Overview

Table 103. Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 104. Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 105. Maac10 Formulas (US) Recent Developments

Table 106. EffePharm (CN) Company Information

Table 107. EffePharm (CN) Introduction and Business Overview

Table 108. EffePharm (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 109. EffePharm (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 110. EffePharm (CN) Recent Developments

Table 111. Bontac (CN) Company Information

Table 112. Bontac (CN) Introduction and Business Overview

Table 113. Bontac (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 114. Bontac (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 115. Bontac (CN) Recent Developments

Table 116. CELFULL (US) Company Information

Table 117. CELFULL (US) Introduction and Business Overview

Table 118. CELFULL (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 119. CELFULL (US) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 120. CELFULL (US) Recent Developments

Table 121. Kingdomway (CN) Company Information

Table 122. Kingdomway (CN) Introduction and Business Overview

Table 123. Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 124. Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 125. Kingdomway (CN) Recent Developments

Table 126. ABA Chemical (CN) Company Information

Table 127. ABA Chemical (CN) Introduction and Business Overview

Table 128. ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 129. ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 130. ABA Chemical (CN) Recent Developments

Table 131. SyncoZymes (CN) Company Information

Table 132. SyncoZymes (CN) Introduction and Business Overview

Table 133. SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 134. SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Product Offerings

Table 135. SyncoZymes (CN) Recent Developments

Table 136. Key Raw Materials Lists

Table 137. Key Suppliers of Raw Materials Lists

Table 138. Nicotinamide Mononucleotide (NMN) Downstream Customers

Table 139. Nicotinamide Mononucleotide (NMN) Distributors List

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Nicotinamide Mononucleotide (NMN) Product Picture

Figure 2. Global Nicotinamide Mononucleotide (NMN) Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 4. Global Nicotinamide Mononucleotide (NMN) Sales Volume (Tons), 2021–2032

Figure 5. Global Nicotinamide Mononucleotide (NMN) Sales Price (US$/Kg), 2021–2032

Figure 6. Nicotinamide Mononucleotide (NMN) Report Years Considered

Figure 7. Global Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Nicotinamide Mononucleotide (NMN) Sales Volume Ranking of Players (Tons), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nicotinamide Mononucleotide (NMN) Revenue in 2025

Figure 10. Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Content ≥98% Picture

Figure 12. Content ＜98% Picture

Figure 13. Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (Tons), 2021 vs 2025 vs 2032

Figure 16. Global Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Nicotinamide Mononucleotide (NMN) Price by Type (US$/Kg), 2021–2032

Figure 18. Enzymatic Catalysis Picture

Figure 19. Microbial Fermentation Picture

Figure 20. Chemical Synthesis Picture

Figure 21. Other Picture

Figure 22. Global Nicotinamide Mononucleotide (NMN) Sales Value by Production Process (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Production Process, 2025 & 2032

Figure 24. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Production Process (Tons), 2021 vs 2025 vs 2032

Figure 25. Global Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Production Process, 2025 & 2032

Figure 26. Global Nicotinamide Mononucleotide (NMN) Price by Production Process (US$/Kg), 2021–2032

Figure 27. Food Grade Picture

Figure 28. Cosmetic Grade Picture

Figure 29. Pharmaceutical Grade Picture

Figure 30. Global Nicotinamide Mononucleotide (NMN) Sales Value by Grade (US$ Million), 2021 vs 2025 vs 2032

Figure 31. Global Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Grade, 2025 & 2032

Figure 32. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Grade (Tons), 2021 vs 2025 vs 2032

Figure 33. Global Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Grade, 2025 & 2032

Figure 34. Global Nicotinamide Mononucleotide (NMN) Price by Grade (US$/Kg), 2021–2032

Figure 35. Product Picture of Health Care Products

Figure 36. Product Picture of Cosmetics

Figure 37. Product Picture of Others

Figure 38. Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 39. Global Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Application, 2025 & 2032

Figure 40. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (Tons), 2021 vs 2025 vs 2032

Figure 41. Global Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Application, 2025 & 2032

Figure 42. Global Nicotinamide Mononucleotide (NMN) Price by Application (US$/Kg), 2021–2032

Figure 43. North America Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 44. North America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032

Figure 45. Europe Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 46. Europe Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032

Figure 47. Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 48. Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2025 vs 2032

Figure 49. South America Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 50. South America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032

Figure 51. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 52. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032

Figure 53. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value (%), 2021–2032

Figure 54. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume (%), 2021–2032

Figure 55. United States Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 56. United States Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

Figure 57. United States Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032

Figure 58. Europe Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 59. Europe Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

Figure 60. Europe Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032

Figure 61. China Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 62. China Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

Figure 63. China Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032

Figure 64. Japan Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 65. Japan Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

Figure 66. Japan Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032

Figure 67. South Korea Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 68. South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

Figure 69. South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032

Figure 70. Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 71. Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

Figure 72. Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032

Figure 73. India Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032

Figure 74. India Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032

Figure 75. India Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032

Figure 76. Nicotinamide Mononucleotide (NMN) Industrial Chain

Figure 77. Nicotinamide Mononucleotide (NMN) Manufacturing Cost Structure

Figure 78. Channels of Distribution (Direct Sales, and Distribution)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Nicotinamide Mononucleotide (NMN) market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Nicotinamide Mononucleotide (NMN) market is 9.2% 2026 to 2032.

Which region is expected to have the highest market share? shouQi

What was the global market size of Nicotinamide Mononucleotide (NMN) in 2026? shouQi

What was the global market size of Nicotinamide Mononucleotide (NMN) in 2032? shouQi

Which companies rank high in the global Nicotinamide Mononucleotide (NMN) market? shouQi

Related Reports

Global Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 190 million in 2025 to US$ 382 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-01
Pages: 156
USD 4900.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nicotinamide Mononucleotide (NMN) market size was US$ 190 million in 2025 and is forecast to reach a readjusted size of US$ 382 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-08-01
Pages: 140
USD 4250.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2026
The global Nicotinamide Mononucleotide (NMN) market was valued at US$ 190 million in 2025 and is anticipated to reach US$ 382 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-08-01
Pages: 144
USD 2900.00
(Single User License)
Nicotinamide Mononucleotide (NMN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-11-03
Pages: 110
USD 3950.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 78
USD 4250.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 418 million in 2024 to US$ 992 million by 2031, at a CAGR of 13.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 144
USD 4900.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2031
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 468 million in 2025 to US$ 992 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period.
Published Date: 2025-04-02
Pages: 141
USD 4900.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2025
The global market for Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
Published Date: 2025-04-02
Pages: 89
USD 2900.00
(Single User License)
Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 109
USD 3950.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2030
Valued at US$ 418 million in 2024, the global Nicotinamide Mononucleotide (NMN) market is forecast to reach US$ 886 million by 2030, at a CAGR of 13.4% during the forecast period.
Published Date: 2024-12-20
Pages: 146
USD 4900.00
(Single User License)

Global Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 190 million in 2025 to US$ 382 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-01
Pages: 156
USD 4900.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nicotinamide Mononucleotide (NMN) market size was US$ 190 million in 2025 and is forecast to reach a readjusted size of US$ 382 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-08-01
Pages: 140
USD 4250.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2026
The global Nicotinamide Mononucleotide (NMN) market was valued at US$ 190 million in 2025 and is anticipated to reach US$ 382 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-08-01
Pages: 144
USD 2900.00 (Single User License)
Nicotinamide Mononucleotide (NMN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-11-03
Pages: 110
USD 3950.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 78
USD 4250.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 418 million in 2024 to US$ 992 million by 2031, at a CAGR of 13.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 144
USD 4900.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2031
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 468 million in 2025 to US$ 992 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period.
Published: 2025-04-02
Pages: 141
USD 4900.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2025
The global market for Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
Published: 2025-04-02
Pages: 89
USD 2900.00 (Single User License)
Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 109
USD 3950.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2030
Valued at US$ 418 million in 2024, the global Nicotinamide Mononucleotide (NMN) market is forecast to reach US$ 886 million by 2030, at a CAGR of 13.4% during the forecast period.
Published: 2024-12-20
Pages: 146
USD 4900.00 (Single User License)